{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:08:44Z","timestamp":1777500524031,"version":"3.51.4"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81573222"],"award-info":[{"award-number":["81573222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10787-018-0484-y","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T16:14:39Z","timestamp":1524672879000},"page":"655-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Emerging role of semaphorin-3A in autoimmune diseases"],"prefix":"10.1007","volume":"26","author":[{"given":"Li-Na","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"484_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","volume":"41","author":"K Ae","year":"1998","unstructured":"Ae K (1998) Angiogenesis: implication for rheumatoid arthritis. Arthritis Rheum 41:951\u2013962","journal-title":"Arthritis Rheum"},{"key":"484_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2353\/ajpath.2009.080987","volume":"174","author":"S Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J (2009) Surveillance of antigen-presenting cells by CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells in autoimmunity. Am J Pathol 174:1575\u20131587. https:\/\/doi.org\/10.2353\/ajpath.2009.080987","journal-title":"Am J Pathol"},{"key":"484_CR3","first-page":"44","volume":"3","author":"J Arizmendi-Vargas","year":"2011","unstructured":"Arizmendi-Vargas J, Carrillo-Ruiz JD, Lopez-Lizarraga ME, Martinez-Menchaca H, Serrato-\u00c1vila JL, Rend\u00f3n-Molina A, Rivera-Silva G (2011) Multiple sclerosis: an overview of the disease and current concepts of its pathophysiology. J Neurosci Behav Health 3:44\u201350","journal-title":"J Neurosci Behav Health"},{"key":"484_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/art.1780260607","volume":"26","author":"AC Bakke","year":"1983","unstructured":"Bakke AC, Kirkland PA, Kitridou RC (1983) T lymphocyte subsets in systemic lupus erythematosus. Arthritis Rheum 26:745\u2013750","journal-title":"Arthritis Rheum"},{"key":"484_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1440-1789.2010.01105.x","volume":"30","author":"V Barresi","year":"2010","unstructured":"Barresi V, Tuccari G (2010) Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Neuropathology 30:537\u2013546. https:\/\/doi.org\/10.1111\/j.1440-1789.2010.01105.x","journal-title":"Neuropathology"},{"key":"484_CR6","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1172\/jci36389","volume":"118","author":"FM Brennan","year":"2008","unstructured":"Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Investig 118:3537\u20133545. https:\/\/doi.org\/10.1172\/jci36389","journal-title":"J Clin Investig"},{"key":"484_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/rheumatology\/35.11.1122","volume":"35","author":"C Bryan","year":"1996","unstructured":"Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. J Rheumatol 35:1122\u20131126","journal-title":"J Rheumatol"},{"key":"484_CR8","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2005-06-2445","volume":"107","author":"A Catalano","year":"2006","unstructured":"Catalano A (2006) Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107:3321\u20133329. https:\/\/doi.org\/10.1182\/blood-2005-06-2445","journal-title":"Blood"},{"key":"484_CR9","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.4049\/jimmunol.0903527","volume":"185","author":"A Catalano","year":"2010","unstructured":"Catalano A (2010) The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. J Immunol 185:6373\u20136383. https:\/\/doi.org\/10.4049\/jimmunol.0903527","journal-title":"J Immunol"},{"key":"484_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/nejmoa010994","volume":"346","author":"A Chang","year":"2002","unstructured":"Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165\u2013173. https:\/\/doi.org\/10.1056\/nejmoa010994","journal-title":"N Engl J Med"},{"key":"484_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clim.2007.04.014","volume":"124","author":"G Clavel","year":"2007","unstructured":"Clavel G et al (2007) Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 124:158\u2013164","journal-title":"Clin Immunol"},{"key":"484_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0092-8674(00)80766-7","volume":"97","author":"SN Committee","year":"1999","unstructured":"Committee SN (1999) Unified nomenclature for the semaphorin\/collapsins. Cell 97:551\u2013552","journal-title":"Cell"},{"key":"484_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1177\/1352458515599848","volume":"21","author":"C Costa","year":"2015","unstructured":"Costa C, Mart\u00ednez-S\u00e1ez E, Guti\u00e9rrez-Franco A, Eixarch H, Castro Z, Ortega-Aznar A, Ram\u00f3n y Cajal S, Montalban X, Espejo C (2015) Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions. Mult Scler J 21:1632\u20131643. https:\/\/doi.org\/10.1177\/1352458515599848","journal-title":"Mult Scler J"},{"key":"484_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clim.2017.05.011","volume":"184","author":"R Cozacov","year":"2017","unstructured":"Cozacov R, Halasz K, Haj T, Vadasz Z (2017) Semaphorin 3A: is a key player in the pathogenesis of asthma. Clin Immunol 184:70\u201372. https:\/\/doi.org\/10.1016\/j.clim.2017.05.011","journal-title":"Clin Immunol"},{"key":"484_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.coi.2010.08.012","volume":"22","author":"GL Cvetanovich","year":"2010","unstructured":"Cvetanovich GL, Hafler DA (2010) Human regulatory T cells in autoimmune diseases. Curr Opin Immunol 22:753\u2013760. https:\/\/doi.org\/10.1016\/j.coi.2010.08.012","journal-title":"Curr Opin Immunol"},{"key":"484_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.reuma.2014.09.004","volume":"11","author":"IRFF Larrinoa de","year":"2015","unstructured":"de Larrinoa IRFF (2015) What is new in systemic lupus erythematosus. Reumatol Clin 11:27\u201332","journal-title":"Reumatol Clin"},{"key":"484_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/exnr.2002.7884","volume":"175","author":"F Winter De","year":"2002","unstructured":"De Winter F et al (2002) Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol 175:61\u201375. https:\/\/doi.org\/10.1006\/exnr.2002.7884","journal-title":"Exp Neurol"},{"key":"484_CR18","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.4049\/jimmunol.166.7.4348","volume":"166","author":"S Delaire","year":"2001","unstructured":"Delaire S, Billard C, Tordjman R, Ch\u00e9dotal A, Elhabazi A, Bensussan A, Boumsell L (2001) Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 166:4348\u20134354","journal-title":"J Immunol"},{"key":"484_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558. https:\/\/doi.org\/10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"484_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/ar433","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O et al (2002) Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4:30","journal-title":"Arthritis Res"},{"key":"484_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O et al (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95:109\u2013116","journal-title":"Circ Res"},{"key":"484_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.molmed.2013.01.003","volume":"19","author":"H Eixarch","year":"2013","unstructured":"Eixarch H, Guti\u00e9rrez-Franco A, Montalban X, Espejo C (2013) Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis. Trends Mol Med 19:157\u2013164. https:\/\/doi.org\/10.1016\/j.molmed.2013.01.003","journal-title":"Trends Mol Med"},{"key":"484_CR23","doi-asserted-by":"publisher","first-page":"s484","DOI":"10.2741\/1080","volume":"8","author":"R Fiore","year":"2003","unstructured":"Fiore R, P\u00fcschel AW (2003) The function of semaphorins during nervous system development. Front Biosci 8:s484\u2013s499","journal-title":"Front Biosci"},{"key":"484_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1006\/mcne.1999.0787","volume":"14","author":"V Gagliardini","year":"1999","unstructured":"Gagliardini V, Fankhauser C (1999) Semaphorin III can induce death in sensory neurons. Mol Cell Neurosci 14:301\u2013316","journal-title":"Mol Cell Neurosci"},{"key":"484_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3760\/cma.j.issn.0376-2491.2017.05.010","volume":"97","author":"H Gao","year":"2017","unstructured":"Gao H et al (2017a) Expression and clinical significance of semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 97:370\u2013374. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2017.05.010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"484_CR26","first-page":"370","volume":"97","author":"H Gao","year":"2017","unstructured":"Gao H, Ma XX, Guo Q, Zou YD, Zhong YC, Xie LF, Shao M, Zhang XW (2017b) Expression and clinical significance of semaphorin 3A in serum and monouclear cells in patients with systemic lupus erythematous. Natl Med J China 97:370\u2013374","journal-title":"Natl Med J China"},{"key":"484_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","volume":"40","author":"SY Guan","year":"2017","unstructured":"Guan SY, Leng RX, Khan MI, Qureshi H, Li XP, Ye DQ, Pan HF (2017) Interleukin-35: a potential therapeutic agent for autoimmune diseases. Inflammation 40:303\u2013310. https:\/\/doi.org\/10.1007\/s10753-016-0453-9","journal-title":"Inflammation"},{"key":"484_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2015.12.005","volume":"163","author":"A Guti\u00e9rrez-Franco","year":"2016","unstructured":"Guti\u00e9rrez-Franco A et al (2016) Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: implications for a therapeutic design. Clin Immunol 163:22\u201333. https:\/\/doi.org\/10.1016\/j.clim.2015.12.005","journal-title":"Clin Immunol"},{"key":"484_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.194.5.669","volume":"194","author":"ES Huseby","year":"2001","unstructured":"Huseby ES, Liggitt D, Brabb T, Schnabel B, \u00d6hl\u00e9n C, Goverman J (2001) A pathogenic role for myelin-specific Cd8\u2009+\u2009T cells in a model for multiple sclerosis. J Exp Med 194:669\u2013676. https:\/\/doi.org\/10.1084\/jem.194.5.669","journal-title":"J Exp Med"},{"key":"484_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.humimm.2009.01.026","volume":"70","author":"JD Ji","year":"2009","unstructured":"Ji JD, Park-Min KH, Ivashkiv LB (2009) Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Hum Immunol 70:211\u2013217. https:\/\/doi.org\/10.1016\/j.humimm.2009.01.026","journal-title":"Hum Immunol"},{"key":"484_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1182\/blood-2004-10-4092","volume":"106","author":"H Kashiwagi","year":"2005","unstructured":"Kashiwagi H (2005) Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A. Blood 106:913\u2013921. https:\/\/doi.org\/10.1182\/blood-2004-10-4092","journal-title":"Blood"},{"key":"484_CR32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1242\/dev.129.3.671","volume":"129","author":"T Kawasaki","year":"2002","unstructured":"Kawasaki T et al (2002) Requirement of neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous system. Development 129:671\u2013680","journal-title":"Development"},{"key":"484_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12026-015-8694-5","volume":"63","author":"SJ Kim","year":"2015","unstructured":"Kim SJ (2015) Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases. Immunol Res 63:113\u2013120. https:\/\/doi.org\/10.1007\/s12026-015-8694-5","journal-title":"Immunol Res"},{"key":"484_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0092-8674(93)90625-Z","volume":"75","author":"AL Kolodkin","year":"1993","unstructured":"Kolodkin AL, Matthes DJ, Goodman CS (1993) The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75:1389\u20131399. https:\/\/doi.org\/10.1016\/0092-8674(93)90625-Z","journal-title":"Cell"},{"key":"484_CR35","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1177\/1352458515608693","volume":"21","author":"D Kremer","year":"2015","unstructured":"Kremer D, Hartung HP, K\u00fcry P (2015) Targeting semaphorins in MS as a treatment strategy to promote remyelination: a tale of mice, rats and men. Mult Scler J 21:1616\u20131617. https:\/\/doi.org\/10.1177\/1352458515608693","journal-title":"Mult Scler J"},{"key":"484_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ics.2005.08.008","volume":"1285","author":"A Kumanogoh","year":"2005","unstructured":"Kumanogoh A et al (2005) Semaphorins in the immune system. Int Congr Ser 1285:202\u2013206. https:\/\/doi.org\/10.1016\/j.ics.2005.08.008","journal-title":"Int Congr Ser"},{"key":"484_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3899\/jrheum.090941","volume":"37","author":"D Kurosaka","year":"2010","unstructured":"Kurosaka D et al (2010) Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol 37:1121\u20131128","journal-title":"J Rheumatol"},{"key":"484_CR38","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/eji.200535601","volume":"36","author":"Y Lepelletier","year":"2006","unstructured":"Lepelletier Y et al (2006) Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 36:1782\u20131793. https:\/\/doi.org\/10.1002\/eji.200535601","journal-title":"Eur J Immunol"},{"key":"484_CR39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/rheumatology\/ker318","volume":"51","author":"K Lerang","year":"2012","unstructured":"Lerang K, Gilboe IM, Gran JT (2012) Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus. Rheumatology (Oxford) 51:663\u2013669. https:\/\/doi.org\/10.1093\/rheumatology\/ker318","journal-title":"Rheumatology (Oxford)"},{"key":"484_CR40","first-page":"202","volume":"15","author":"E LeRoy","year":"1988","unstructured":"LeRoy E (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"484_CR41","first-page":"202","volume":"15","author":"EC LeRoy","year":"1998","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1998) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"484_CR42","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12026-016-8808-8","volume":"64","author":"HM Li","year":"2016","unstructured":"Li HM et al (2016) Emerging role of adipokines in systemic lupus erythematosus. Immunol Res 64:820\u2013830. https:\/\/doi.org\/10.1007\/s12026-016-8808-8","journal-title":"Immunol Res"},{"key":"484_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0925-4773(00)00545-1","volume":"101","author":"S Loes","year":"2001","unstructured":"Loes S, Kettunen P, Kvinnsland IH, Taniguchi M, Fujisawa H, Luukko K (2001) Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. Mech Dev 101:191\u2013194. https:\/\/doi.org\/10.1016\/S0925-4773(00)00545-1","journal-title":"Mech Dev"},{"key":"484_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","volume":"10","author":"FE Lund","year":"2010","unstructured":"Lund FE, Randall TD (2010) Effector and regulatory B cells: modulators of CD4\u2009+\u2009T cell immunity. Nat Rev Immunol 10:236. https:\/\/doi.org\/10.1038\/nri2729","journal-title":"Nat Rev Immunol"},{"key":"484_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0092-8674(93)80064-L","volume":"75","author":"Y Luo","year":"1993","unstructured":"Luo Y, Raible D, Raper JA (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75:217\u2013227. https:\/\/doi.org\/10.1016\/0092-8674(93)80064-L","journal-title":"Cell"},{"key":"484_CR46","first-page":"641","volume":"20","author":"Z Mackiewicz","year":"2002","unstructured":"Mackiewicz Z, Sukura A, Povilenaite D, Ceponis A, Virtanen I, Hukkanen M, Konttinen YT (2002) Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol 20:641\u2013646","journal-title":"Clin Exp Rheumatol"},{"key":"484_CR47","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1523\/jneurosci.0702-05.2006","volume":"26","author":"HH Majed","year":"2006","unstructured":"Majed HH et al (2006) A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J Neurosci 26:1730\u20131738. https:\/\/doi.org\/10.1523\/jneurosci.0702-05.2006","journal-title":"J Neurosci"},{"key":"484_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0896-6273(95)90333-X","volume":"14","author":"EK Messersmith","year":"1995","unstructured":"Messersmith EK, Leonardo ED, Shatz CJ, Tessier-Lavigne M, Goodman M, Kolodkin AL (1995) Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord. Neuron 14:949\u2013959","journal-title":"Neuron"},{"key":"484_CR49","first-page":"233","volume":"146","author":"HQ Miao","year":"1999","unstructured":"Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M (1999) Neuropilin-1 mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146:233\u2013242","journal-title":"J Cell Biol"},{"key":"484_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-008-9263-7","volume":"29","author":"M Mizui","year":"2009","unstructured":"Mizui M, Kumanogoh A, Kikutani H (2009) Immune semaphorins: novel features of neural guidance molecules. J Clin Immunol 29:1\u201311. https:\/\/doi.org\/10.1007\/s10875-008-9263-7","journal-title":"J Clin Immunol"},{"key":"484_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56:481\u2013490","journal-title":"J Clin Pathol"},{"key":"484_CR52","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1182\/blood-2007-06096529","volume":"111","author":"S Moretti","year":"2008","unstructured":"Moretti S, Procopio A, Lazzarini R, Rippo MR, Testa R, Marra M, Tamagnone L, Catalano A (2008) Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. Blood 111:2290\u20132299. https:\/\/doi.org\/10.1182\/blood-2007-06096529","journal-title":"Blood"},{"key":"484_CR53","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra SV et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377:721\u2013731. https:\/\/doi.org\/10.1016\/s0140-6736(10)61354-2","journal-title":"Lancet"},{"key":"484_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/bonekey.2012.183","volume":"1","author":"T Negishi-Koga","year":"2012","unstructured":"Negishi-Koga T, Takayanagi H (2012) Bone cell communication factors and semaphorins. Bonekey Rep 1:183","journal-title":"Bonekey Rep"},{"key":"484_CR55","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1016\/j.febslet.2011.03.033","volume":"585","author":"T Okuno","year":"2011","unstructured":"Okuno T, Nakatsuji Y, Kumanogoh A (2011) The role of immune semaphorins in multiple sclerosis. FEBS Lett 585:3829\u20133835. https:\/\/doi.org\/10.1016\/j.febslet.2011.03.033","journal-title":"FEBS Lett"},{"key":"484_CR56","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/annrheumdis-2016-eular.5233","volume":"75","author":"ASD Olewicz-Gawlik","year":"2016","unstructured":"Olewicz-Gawlik ASD, Samborski W (2016) Soluble semaphorin 3a and neuropilin-1: new markers for dysregulation of angiogenesis in systemic sclerosis. Ann Rheum Dis 75:749. https:\/\/doi.org\/10.1136\/annrheumdis-2016-eular.5233","journal-title":"Ann Rheum Dis"},{"key":"484_CR57","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.humpath.2006.04.031","volume":"37","author":"R Osada","year":"2006","unstructured":"Osada R, Horiuchi A, Kikuchi N, Ohira S, Ota M, Katsuyama Y, Konishi I (2006) Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum Pathol 37:1414\u20131425","journal-title":"Hum Pathol"},{"key":"484_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cytogfr.2013.09.001","volume":"24","author":"HF Pan","year":"2013","unstructured":"Pan HF, Leng RX, Li XP, Zheng SG, Ye DQ (2013a) Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev 24:515\u2013522","journal-title":"Cytokine Growth Factor Rev"},{"key":"484_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cytogfr.2012.07.002","volume":"24","author":"HF Pan","year":"2013","unstructured":"Pan HF, Li XP, Zheng SG, Ye DQ (2013b) Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev 24:51\u201357. https:\/\/doi.org\/10.1016\/j.cytogfr.2012.07.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"484_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209124.140","author":"SG Perez","year":"2016","unstructured":"Perez SG et al (2016) Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes. Anna Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209124.140","journal-title":"Anna Rheum Dis"},{"key":"484_CR61","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/brain\/awr022","volume":"134","author":"G Piaton","year":"2011","unstructured":"Piaton G et al (2011) Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134:1156\u20131167. https:\/\/doi.org\/10.1093\/brain\/awr022","journal-title":"Brain"},{"key":"484_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0896-6273(95)90332-1","volume":"14","author":"AW P\u00fcschel","year":"1995","unstructured":"P\u00fcschel AW, Adams RH, Betz H (1995) Murine semaphorin D\/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension. Neuron 14:941\u2013948","journal-title":"Neuron"},{"key":"484_CR63","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/jci58644","volume":"122","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Investig 122:1164\u20131171. https:\/\/doi.org\/10.1172\/jci58644","journal-title":"J Clin Investig"},{"key":"484_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2017.02.013","volume":"610","author":"M Rezaeepoor","year":"2017","unstructured":"Rezaeepoor M, Shapoori S, Ganjalikhani-hakemi M, Etemadifar M, Alsahebfosoul F, Eskandari N, Mansourian M (2017) Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients. Gene 610:59\u201363. https:\/\/doi.org\/10.1016\/j.gene.2017.02.013","journal-title":"Gene"},{"key":"484_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/glia.10210","volume":"42","author":"J Rieger","year":"2003","unstructured":"Rieger J, Wick W, Weller M (2003) Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42:379\u2013389. https:\/\/doi.org\/10.1002\/glia.10210","journal-title":"Glia"},{"key":"484_CR66","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/annrheumdis-2014-eular.2948","volume":"73","author":"D Rimar","year":"2014","unstructured":"Rimar D, Rosner I, Slobodin G, Boulman N, Rozenbaum M, Halasz K, Haj T, Jiries N, Kaly L, Vadasz Z (2014) Semaphorin 3a as a possible immunoregulator in systemic sclerosis. Ann Rheum Dis 73:868. https:\/\/doi.org\/10.1136\/annrheumdis-2014-eular.2948","journal-title":"Ann Rheum Dis"},{"key":"484_CR67","doi-asserted-by":"publisher","first-page":"O46","DOI":"10.1186\/1546-0096-13-s1-o46","volume":"13","author":"D Rimar","year":"2015","unstructured":"Rimar D, Rosner I, Slobodin G, Rozenbaum M, Halasz K, Jiries N, Kaly L, Boulman N, Vadasz Z (2015a) Semaphorin 3A, a potential immune regulator in Familial Mediterranean fever. Pediatr Rheumatol 13:O46. https:\/\/doi.org\/10.1186\/1546-0096-13-s1-o46","journal-title":"Pediatr Rheumatol"},{"key":"484_CR68","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00296-015-3269-2","volume":"35","author":"D Rimar","year":"2015","unstructured":"Rimar D et al (2015b) Semaphorin 3A: an immunoregulator in systemic sclerosis. Rheumatol Int 35:1625\u20131630. https:\/\/doi.org\/10.1007\/s00296-015-3269-2","journal-title":"Rheumatol Int"},{"key":"484_CR69","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","volume":"75","author":"E Romano","year":"2016","unstructured":"Romano E et al (2016) Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis. Ann Rheum Dis 75:1541\u20131549. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207483","journal-title":"Ann Rheum Dis"},{"key":"484_CR70","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00018-008-8518-z","volume":"66","author":"L Roth","year":"2008","unstructured":"Roth L, Koncina E, Satkauskas S, Cr\u00e9mel G, Aunis D, Bagnard D (2008) The many faces of semaphorins: from development to pathology. Cell Mol Life Sci 66:649\u2013666. https:\/\/doi.org\/10.1007\/s00018-008-8518-z","journal-title":"Cell Mol Life Sci"},{"key":"484_CR71","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","volume":"44","author":"M Rubio-Rivas","year":"2014","unstructured":"Rubio-Rivas M, Royo C, Sime\u00f3n CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208\u2013219. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.010","journal-title":"Semin Arthritis Rheum"},{"key":"484_CR72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69:20\u201328. https:\/\/doi.org\/10.1136\/ard.2008.101766","journal-title":"Ann Rheum Dis"},{"key":"484_CR73","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s0014-4886(03)00046-3","volume":"183","author":"M Scarlato","year":"2003","unstructured":"Scarlato M (2003) Induction of neuropilins-1 and -2 and their ligands, Sema3A, Sema3F, and VEGF, during Wallerian degeneration in the peripheral nervous system. Exp Neurol 183:489\u2013498. https:\/\/doi.org\/10.1016\/s0014-4886(03)00046-3","journal-title":"Exp Neurol"},{"key":"484_CR74","doi-asserted-by":"publisher","first-page":"s157","DOI":"10.1016\/j.humimm.2009.09.322","volume":"70","author":"L Schlahsa","year":"2009","unstructured":"Schlahsa L, Zenk J, Aufderbeck S, Figueiredo C, Blasczyk R (2009) Soluble semaphorin 3A regulates the immune response. Hum Immunol 70:s157","journal-title":"Hum Immunol"},{"key":"484_CR75","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1073\/pnas.1008721108","volume":"108","author":"BD Solomon","year":"2011","unstructured":"Solomon BD, Mueller C, Chae WJ, Alabanza LM, Bynoe MS (2011) Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108:2040\u20132045. https:\/\/doi.org\/10.1073\/pnas.1008721108","journal-title":"Proc Natl Acad Sci USA"},{"key":"484_CR76","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66:940\u2013944. https:\/\/doi.org\/10.1136\/ard.2006.066068","journal-title":"Ann Rheum Dis"},{"key":"484_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki K, Kumanogoh A, Kikutani H (2008) Semaphorins and their receptors in immune cell interactions. Nat Immunol 9:17\u201323. https:\/\/doi.org\/10.1038\/ni1553","journal-title":"Nat Immunol"},{"key":"484_CR78","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1523\/jneurosci.4930-10.2011","volume":"31","author":"YA Syed","year":"2011","unstructured":"Syed YA, Hand E, Mobius W, Zhao C, Hofer M, Nave KA, Kotter MR (2011) Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci 31:3719\u20133728. https:\/\/doi.org\/10.1523\/jneurosci.4930-10.2011","journal-title":"J Neurosci"},{"key":"484_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-14-40","volume":"14","author":"S Takagawa","year":"2013","unstructured":"Takagawa S, Nakamura F, Kumagai K, Nagashima Y, Goshima Y, Saito T (2013a) Decreased Semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis. BMC Musculoskelet Disord 14:1\u201311","journal-title":"BMC Musculoskelet Disord"},{"key":"484_CR80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2474-14-40","volume":"14","author":"S Takagawa","year":"2013","unstructured":"Takagawa S, Nakamura F, Kumagai K, Nagashima Y, Goshima Y, Saito T (2013b) Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis. BMC Musculoskelet Disord 14:40. https:\/\/doi.org\/10.1186\/1471-2474-14-40","journal-title":"BMC Musculoskelet Disord"},{"key":"484_CR81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0092-8674(00)80062-8","volume":"99","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, Kalb RG, Fujisawa H, Strittmatter SM (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3a receptors. Cell 99:59\u201369","journal-title":"Cell"},{"key":"484_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/cmi.2009.111","volume":"7","author":"H Takamatsu","year":"2010","unstructured":"Takamatsu H, Okuno T, Kumanogoh A (2010a) Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol 7:83\u201388. https:\/\/doi.org\/10.1038\/cmi.2009.111","journal-title":"Cell Mol Immunol"},{"key":"484_CR83","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/ni.1885","volume":"11","author":"H Takamatsu","year":"2010","unstructured":"Takamatsu H et al (2010b) Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol 11:594\u2013600. https:\/\/doi.org\/10.1038\/ni.1885","journal-title":"Nat Immunol"},{"key":"484_CR84","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0896-6273(00)80368-2","volume":"19","author":"M Taniguchi","year":"1997","unstructured":"Taniguchi M, Yuasa S, Fujisawa H, Naruse I, Saga S, Mishina M, Yagi T (1997) Disruption of semaphorin III\/D gene causes severe abnormality in peripheral nerve projection. Neuron 19:519\u2013530. https:\/\/doi.org\/10.1016\/S0896-6273(00)80368-2","journal-title":"Neuron"},{"key":"484_CR85","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/eji.201040847","volume":"41","author":"H Tran-Van","year":"2011","unstructured":"Tran-Van H, Avota E, Bortlein C, Mueller N, Schneider-Schaulies S (2011) Measles virus modulates dendritic cell\/T-cell communication at the level of plexinA1\/neuropilin-1 recruitment and activity. Eur J Immunol 41:151\u2013163. https:\/\/doi.org\/10.1002\/eji.201040847","journal-title":"Eur J Immunol"},{"key":"484_CR86","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1212\/wnl.53.3.466","volume":"53","author":"N Tubridy","year":"1999","unstructured":"Tubridy N et al (1999) The effect of anti-\u03b14 integrin antibody on brain lesion activity in MS. Neurology 53:466. https:\/\/doi.org\/10.1212\/wnl.53.3.466","journal-title":"Neurology"},{"key":"484_CR87","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1177\/0961203312456753","volume":"21","author":"Z Vadasz","year":"2012","unstructured":"Vadasz Z, Toubi E (2012) Semaphorin 3A: a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus. Lupus 21:1266\u20131270. https:\/\/doi.org\/10.1177\/0961203312456753","journal-title":"Lupus"},{"key":"484_CR88","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12016-013-8360-4","volume":"47","author":"Z Vadasz","year":"2013","unstructured":"Vadasz Z, Toubi E (2013) Semaphorins: their dual role in regulating immune-mediated diseases. Clinic Rev Allerg Immunol 47:17\u201325. https:\/\/doi.org\/10.1007\/s12016-013-8360-4","journal-title":"Clinic Rev Allerg Immunol"},{"key":"484_CR89","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.autrev.2010.07.014","volume":"9","author":"Z Vadasz","year":"2010","unstructured":"Vadasz Z, Attias D, Kessel A, Toubi E (2010) Neuropilins and semaphorins: from angiogenesis to autoimmunity. Autoimmun Rev 9:825\u2013829. https:\/\/doi.org\/10.1016\/j.autrev.2010.07.014","journal-title":"Autoimmun Rev"},{"key":"484_CR90","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1177\/0961203311417034","volume":"20","author":"Z Vadasz","year":"2011","unstructured":"Vadasz Z, Ben-Izhak O, Bejar J, Sabo E, Kessel A, Storch S, Toubi E (2011) The involvement of immune semaphorins and neuropilin-1 in lupus nephritis. Lupus 20:1466\u20131473. https:\/\/doi.org\/10.1177\/0961203311417034","journal-title":"Lupus"},{"key":"484_CR91","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/ar3881","volume":"14","author":"Z Vadasz","year":"2012","unstructured":"Vadasz Z et al (2012a) Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Res Ther 14:R146. https:\/\/doi.org\/10.1186\/ar3881","journal-title":"Arthritis Res Ther"},{"key":"484_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3881","volume":"14","author":"Z Vadasz","year":"2012","unstructured":"Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D, Kessel A, Kessler O, Neufeld G, Toubi E (2012b) Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Res Ther 14:1\u20138","journal-title":"Arthritis Res Ther"},{"key":"484_CR93","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.semarthrit.2013.11.010","volume":"43","author":"Z Vadasz","year":"2014","unstructured":"Vadasz Z et al (2014) A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Semin Arthritis Rheum 43:767\u2013771. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.11.010","journal-title":"Semin Arthritis Rheum"},{"key":"484_CR94","doi-asserted-by":"publisher","first-page":"254245","DOI":"10.1155\/2015\/254245","volume":"2015","author":"Z Vadasz","year":"2015","unstructured":"Vadasz Z, Peri R, Eiza N, Slobodin G, Balbir-Gurman A, Toubi E (2015a) The expansion of CD25 high IL-10 high FoxP3 high B regulatory cells is in association with SLE disease activity. J Immunol Res 2015:254245. https:\/\/doi.org\/10.1155\/2015\/254245","journal-title":"J Immunol Res"},{"key":"484_CR95","doi-asserted-by":"publisher","first-page":"e0125860","DOI":"10.1371\/journal.pone.0125860","volume":"10","author":"Z Vadasz","year":"2015","unstructured":"Vadasz Z, Rainis T, Nakhleh A, Haj T, Bejar J, Halasz K, Toubi E (2015b) The involvement of immune semaphorins in the pathogenesis of inflammatory bowel diseases (IBDs). PLoS ONE 10:e0125860. https:\/\/doi.org\/10.1371\/journal.pone.0125860","journal-title":"PLoS ONE"},{"key":"484_CR96","doi-asserted-by":"publisher","first-page":"A61","DOI":"10.1136\/annrheumdis-2015-207259.140","volume":"74","author":"Z Vadasz","year":"2015","unstructured":"Vadasz Z, Rimar D, Toubi E (2015c) A6.14 Semaphorin 3A, an immunoregulator and potential biomarker for disease severity in systemic sclerosis. Ann Rheum Dis 74:A61. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207259.140","journal-title":"Ann Rheum Dis"},{"key":"484_CR97","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/S0925-4773(03)00108-4","volume":"199","author":"G Villegas","year":"2002","unstructured":"Villegas G, Tufro A (2002) Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. Mech Dev 199:S149\u2013S153","journal-title":"Mech Dev"},{"key":"484_CR98","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1093\/brain\/awm202","volume":"130","author":"A Williams","year":"2007","unstructured":"Williams A et al (2007) Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130:2554\u20132565. https:\/\/doi.org\/10.1093\/brain\/awm202","journal-title":"Brain"},{"key":"484_CR99","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cne.903610209","volume":"361","author":"DE Wright","year":"1995","unstructured":"Wright DE, White FR, Gerfen RW, Silos-Santiago I, Snider W (1995) The guidance molecule semaphorin III is expressed in regions of spinal cord and periphery avoided by growing sensory axons. J Comp Neurol 361:321\u2013333","journal-title":"J Comp Neurol"},{"key":"484_CR100","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/intimm\/dxn006","volume":"20","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto M et al (2008) Plexin-A4 negatively regulates T lymphocyte responses. Int Immunol 20:413\u2013420. https:\/\/doi.org\/10.1093\/intimm\/dxn006","journal-title":"Int Immunol"},{"key":"484_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/gb-2006-7-3-211","volume":"7","author":"U Yazdani","year":"2006","unstructured":"Yazdani U, Terman JR (2006) The semaphorins. Genome Biol 7:211. https:\/\/doi.org\/10.1186\/gb-2006-7-3-211","journal-title":"Genome Biol"},{"key":"484_CR102","doi-asserted-by":"publisher","first-page":"A820","DOI":"10.1136\/annrheumdis-2013-eular.2437","volume":"72","author":"Y Yoshida","year":"2014","unstructured":"Yoshida Y et al (2014) AB0114 Semaphorin3A and semaphorin4d in rheumatoid arthritis. Ann Rheum Dis 72:A820. https:\/\/doi.org\/10.1136\/annrheumdis-2013-eular.2437","journal-title":"Ann Rheum Dis"},{"key":"484_CR103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2014.01.004","volume":"49","author":"C Yu","year":"2014","unstructured":"Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 49:10\u201313","journal-title":"J Autoimmun"},{"key":"484_CR104","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/imr.12163","volume":"259","author":"X Yuan","year":"2014","unstructured":"Yuan X, Cheng G, Malek TR (2014) The importance of regulatory T-cell heterogeneity in maintaining self-tolerance. Immunol Rev 259:103\u2013114. https:\/\/doi.org\/10.1111\/imr.12163","journal-title":"Immunol Rev"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-0484-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:31:42Z","timestamp":1661041902000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-0484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-0484-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}